pleural effusion

From Aaushi
Jump to navigation Jump to search

Introduction

Pleural effusions are classified as transudative or exudative.

Etiology

Pathology

Clinical manifestations

Laboratory

thoracentesis

* if pleural effusion is classified as exudate if either LDH or protein is elevated or transudative if neither one is elevated

* see Light's criteria

* in the setting of heart failure, only one of the criteria may be met, i,e. mixed transudative & exudative effusion

pleural biopsy

* useful if tuberculin skin test negative

* adenosine deaminase in pleural fluid is preferable to pleural biopsy for tuberculosis if pleural fluid lymphocytes > 75%

* lymphocyte predominant pleural fluid with pH < 7.4 & low pleural fluid glucose suggests pleural tuberculosis (see Management: for pleural fluid lymphocytosis)

* 2 non-diagnostic thoracenteses should be performed prior to pleural biopsy for diagnosis of malignancy[3]

* thoracoscopy with direct visualization & pleural biopsy after 2 non-diagnostic thoracenteses for exudative pleural effusions[3]

* if pleural thickening or nodularity is seen on CT, image-guided needle biopsy (closed pleural biopsy) may be preferred[24], but MKSAP20 dismisses this notion[3]

Radiology

Complications

Management

* TIPS: transjugular intrahepatic portosystemic shunt[3]

More general terms

More specific terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th edition, Ewald & McKenzie (eds) Little, Brown & Co, 1995, pg 259
  2. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 771
  3. 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 3.14 3.15 3.16 3.17 3.18 3.19 3.20 3.21 3.22 3.23 3.24 3.25 3.26 3.27 3.28 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
    Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
  4. Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1146
  5. 5.0 5.1 Davies HE et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: The TIME2 randomized controlled trial. JAMA 2012 Jun 13; 307:2383. PMID: https://pubmed.ncbi.nlm.nih.gov/22610520
  6. Light RW. Pleural effusions. Med Clin North Am. 2011 Nov;95(6):1055-70 PMID: https://pubmed.ncbi.nlm.nih.gov/22032427
    Light RW. Clinical practice. Pleural effusion. N Engl J Med. 2002 Jun 20;346(25):1971-7. PMID: https://pubmed.ncbi.nlm.nih.gov/12075059
  7. 7.0 7.1 Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol. 1994 Aug;7(6):665-8. PMID: https://pubmed.ncbi.nlm.nih.gov/7991525
  8. 8.0 8.1 Romero-Candeira S, Fernandez C, Martin C et al Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med. 2001 Jun 15;110(9):681-6. PMID: https://pubmed.ncbi.nlm.nih.gov/11403751
  9. 9.0 9.1 9.2 Davies HE et al for the BTS Pleural Disease Guideline Group Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010 Aug;65(Suppl 2):ii41-53 PMID: https://pubmed.ncbi.nlm.nih.gov/20696693 corresponding NGC guideline withdrawn Dec 2015
  10. 10.0 10.1 Geriatric Review Syllabus, 8th edition (GRS8) Durso SC and Sullivan GN (eds) American Geriatrics Society, 2013
    Geriatric Review Syllabus, 11th edition (GRS11) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2022
  11. 11.0 11.1 van den Toorn LM1, Schaap E, Surmont VF Management of recurrent malignant pleural effusions with a chronic indwelling pleural catheter. Lung Cancer. 2005 Oct;50(1):123-7. PMID: https://pubmed.ncbi.nlm.nih.gov/15998551
  12. 12.0 12.1 12.2 Huggins JT, Doelken P, Sahn SA. Intrapleural therapy. Respirology. 2011 Aug;16(6):891-9. PMID: https://pubmed.ncbi.nlm.nih.gov/21672085
  13. 13.0 13.1 Rahman NM, Maskell NA, Davies CW et al The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010 Mar;137(3):536-43. PMID: https://pubmed.ncbi.nlm.nih.gov/19820073
  14. Hooper C, Lee YC, Maskell N; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii4-17. PMID: https://pubmed.ncbi.nlm.nih.gov/20696692
  15. Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010 Aug;65 Suppl 2:ii32-40. PMID: https://pubmed.ncbi.nlm.nih.gov/20696691
  16. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest. 2006 Feb;129(2):362-8. PMID: https://pubmed.ncbi.nlm.nih.gov/16478853
  17. Wong CL, Holroyd-Leduc J, Straus SE. Does this patient have a pleural effusion? JAMA. 2009 Jan 21;301(3):309-17 PMID: https://pubmed.ncbi.nlm.nih.gov/19155458
  18. 18.0 18.1 18.2 Walker SP, Morley AJ, Stadon L et al. Nonmalignant pleural effusions: A prospective study of 356 consecutive unselected patients. Chest 2017 May; 151:1099 PMID: https://pubmed.ncbi.nlm.nih.gov/28025056
  19. 19.0 19.1 Rahman NM, Maskell NA, West A et al Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011 Aug 11;365(6):518-26. PMID: https://pubmed.ncbi.nlm.nih.gov/21830966 Free Article
  20. 20.0 20.1 Girdhar A, Shujaat A, Bajwa A. Management of infectious processes of the pleural space: a review Pulm Med. 2012;2012:816502 PMID: https://pubmed.ncbi.nlm.nih.gov/22536502 PMCID: PMC3317076 Free PMC article
  21. 21.0 21.1 Feller-Kopman D, Light R. Pleural Disease. N Engl J Med. 2018 Feb 22;378(8):740-751. PMID: https://pubmed.ncbi.nlm.nih.gov/29466146
  22. 22.0 22.1 NEJM Knowledge+ Question of the Week. June 23, 2020 https://knowledgeplus.nejm.org/question-of-week/566/
    Zhou Q et al. Diagnostic accuracy of T-cell interferon-gamma release assays in tuberculous pleurisy: a meta-analysis. Respirology 2011 Feb 9; 16:473 PMID: https://pubmed.ncbi.nlm.nih.gov/21299686
    Keng LT et al. Evaluating pleural ADA, ADA2, IFN-gamma and IGRA for diagnosing tuberculous pleurisy. J Infect 2013 Jun 26; 67:294 PMID: https://pubmed.ncbi.nlm.nih.gov/23796864
  23. Ferreiro L, Suarez-Antelo J, Alvarez-Dobano JM et al Malignant Pleural Effusion: Diagnosis and Management. Can Respir J. 2020 Sep 23;2020:2950751. PMID: https://pubmed.ncbi.nlm.nih.gov/33273991 PMCID: PMC7695997 Free PMC article. Review.
  24. 24.0 24.1 Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143:e142S-e165S. PMID: https://pubmed.ncbi.nlm.nih.gov/23649436
  25. Kassirian S, Hinton SN, Cuninghame S, et al. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis. Thorax. 2023;78(1):32-40. PMID: https://pubmed.ncbi.nlm.nih.gov/35110369
  26. 26.0 26.1 26.2 Addala DN et al. Incidence of discordant pleural fluid exudates and diagnostic patterns: A retrospective cohort study. Chest 2025 Jun 28; [e-pub]. PMID: https://pubmed.ncbi.nlm.nih.gov/40588125 Free article https://journal.chestnet.org/article/S0012-3692(25)00815-3/fulltext
  27. 27.0 27.1 Shafiq M, Feller-Kopman D. Management of malignant pleural effusions. Clin Chest Med. 2020;41:259-67. PMID: https://pubmed.ncbi.nlm.nih.gov/32402361